{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:34:33Z","timestamp":1786988073726,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,24]],"date-time":"2026-11-24T00:00:00Z","timestamp":1795478400000},"content-version":"am","delay-in-days":327,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014571","name":"Siteman Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007338","name":"Foundation for Barnes-Jewish Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NIH NCI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118385","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T02:38:48Z","timestamp":1763692728000},"page":"118385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"P3","title":["Inhibitors of membrane associated serine proteases block replication of coronavirus SARS-CoV-2 and influenza virus H1N1"],"prefix":"10.1016","volume":"302","author":[{"given":"Victoria","family":"Banas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuljeet","family":"Seehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Mahoney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Alisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yevhenii","family":"Kyriukha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Weiland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Fath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenfu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Traci","family":"Bricker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Tartell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrianus C.M.","family":"Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9888-5411","authenticated-orcid":false,"given":"James W.","family":"Janetka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejmech.2025.118385_bib1","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3390\/ijms23031351","article-title":"The transmembrane protease TMPRSS2 as a therapeutic target for COVID-19 treatment","volume":"23","author":"Wettstein","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.ejmech.2025.118385_bib2","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202000786","article-title":"TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells","volume":"3","author":"Bestle","year":"2020","journal-title":"Life Sci. Alliance"},{"issue":"2","key":"10.1016\/j.ejmech.2025.118385_bib3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.118385_bib4","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.REV120.015980","article-title":"Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection","volume":"296","author":"Fuentes-Prior","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118385_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"43","key":"10.1016\/j.ejmech.2025.118385_bib6","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2108728118","article-title":"A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells","volume":"118","author":"Mahoney","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7909","key":"10.1016\/j.ejmech.2025.118385_bib7","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41586-022-04661-w","article-title":"A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic","volume":"605","author":"Shapira","year":"2022","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ejmech.2025.118385_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01903-23","article-title":"Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19","volume":"98","author":"Boon","year":"2024","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.ejmech.2025.118385_bib9","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1158\/2159-8290.CD-13-1010","article-title":"The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis","volume":"4","author":"Lucas","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejmech.2025.118385_bib10","article-title":"Mechanism-based macrocyclic inhibitors of serine proteases","author":"Vishnu","year":"2024","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118385_bib11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00018-023-05071-5","article-title":"Inhibition of autocrine HGF maturation overcomes cetuximab resistance in colorectal cancer","volume":"81","author":"Jones","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2025.118385_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216286","article-title":"HGF\/c-Met pathway inhibition combined with chemotherapy increases cytotoxic T-cell infiltration and inhibits pancreatic tumour growth and metastasis","volume":"568","author":"Mekapogu","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2025.118385_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/1878-0261.13545\/v2\/response1","article-title":"Hepsin promotes breast tumor growth signaling via the TGFbeta-EGFR axis","author":"Belitskin","year":"2023","journal-title":"Mol. Oncol."},{"issue":"24","key":"10.1016\/j.ejmech.2025.118385_bib14","doi-asserted-by":"crossref","first-page":"18158","DOI":"10.1021\/acs.jmedchem.1c01671","article-title":"Macrocyclic inhibitors of HGF-activating serine proteases overcome resistance to receptor tyrosine kinase inhibitors and block lung cancer progression","volume":"64","author":"Damalanka","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118385_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s42003-018-0255-8","article-title":"Hepatocyte growth factor activator inhibitor-2 stabilizes Epcam and maintains epithelial organization in the mouse intestine","volume":"2","author":"Kawaguchi","year":"2019","journal-title":"Commun. Biol."},{"issue":"9","key":"10.1016\/j.ejmech.2025.118385_bib16","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1039\/C9MD00234K","article-title":"Piperidine carbamate peptidomimetic inhibitors of the serine proteases HGFA, matriptase and hepsin","volume":"10","author":"Damalanka","year":"2019","journal-title":"Medchemcomm"},{"issue":"7","key":"10.1016\/j.ejmech.2025.118385_bib17","doi-asserted-by":"crossref","first-page":"743","DOI":"10.4155\/fmc-2018-0446","article-title":"Recent progress on inhibitors of the type II transmembrane serine proteases, hepsin, matriptase and matriptase-2","volume":"11","author":"Damalanka","year":"2019","journal-title":"Future Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118385_bib18","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1021\/acs.jmedchem.8b01536","article-title":"Discovery of selective matriptase and hepsin serine protease inhibitors: useful chemical tools for cancer cell biology","volume":"62","author":"Damalanka","year":"2019","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2025.118385_bib19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.molmed.2009.05.003","article-title":"Type II transmembrane serine proteases in cancer and viral infections","volume":"15","author":"Choi","year":"2009","journal-title":"Trends Mol. Med."},{"issue":"11","key":"10.1016\/j.ejmech.2025.118385_bib20","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/13543776.2020.1817390","article-title":"Inhibitors of type II transmembrane serine proteases in the treatment of diseases of the respiratory tract - a review of patent literature","volume":"30","author":"Murza","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"issue":"24","key":"10.1016\/j.ejmech.2025.118385_bib21","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1128\/JVI.05300-11","article-title":"Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease","volume":"85","author":"Bertram","year":"2011","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.ejmech.2025.118385_bib22","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1128\/JVI.02232-10","article-title":"Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response","volume":"85","author":"Glowacka","year":"2011","journal-title":"J. Virol."},{"issue":"23","key":"10.1016\/j.ejmech.2025.118385_bib23","doi-asserted-by":"crossref","first-page":"12552","DOI":"10.1128\/JVI.01890-13","article-title":"Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2","volume":"87","author":"Shirato","year":"2013","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118385_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34859-w","article-title":"Functional analysis of potential cleavage sites in the MERS-coronavirus spike protein","volume":"8","author":"Kleine-Weber","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118385_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-1-0716-0211-9_2","article-title":"Evaluating MERS-CoV entry pathways","volume":"2099","author":"Qing","year":"2020","journal-title":"Methods Mol. Biol."},{"issue":"21","key":"10.1016\/j.ejmech.2025.118385_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00649-19","article-title":"TMPRSS2 is the major activating protease of influenza A virus in primary human airway cells and influenza B virus in human type II pneumocytes","volume":"93","author":"Limburg","year":"2019","journal-title":"J. Virol."},{"issue":"19","key":"10.1016\/j.ejmech.2025.118385_bib27","doi-asserted-by":"crossref","first-page":"9896","DOI":"10.1128\/JVI.01118-06","article-title":"Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium","volume":"80","author":"Bottcher","year":"2006","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.ejmech.2025.118385_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003774","article-title":"Tmprss2 is essential for influenza H1N1 virus pathogenesis in mice","volume":"9","author":"Hatesuer","year":"2013","journal-title":"PLoS Pathog."},{"issue":"10","key":"10.1016\/j.ejmech.2025.118385_bib29","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1128\/JVI.03677-13","article-title":"The host protease TMPRSS2 plays a major role in in vivo replication of emerging H7N9 and seasonal influenza viruses","volume":"88","author":"Sakai","year":"2014","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118385_bib30","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1128\/JVI.02320-12","article-title":"Matriptase, HAT, and TMPRSS2 activate the hemagglutinin of H9N2 influenza A viruses","volume":"87","author":"Baron","year":"2013","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.ejmech.2025.118385_bib31","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1128\/JVI.03005-12","article-title":"Matriptase proteolytically activates influenza virus and promotes multicycle replication in the human airway epithelium","volume":"87","author":"Beaulieu","year":"2013","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118385_bib32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/irv.12707","article-title":"Human matriptase\/ST 14 proteolytically cleaves H7N9 hemagglutinin and facilitates the activation of influenza A\/Shanghai\/2\/2013 virus in cell culture","volume":"14","author":"Whittaker","year":"2020","journal-title":"Influenza Other Respir Viruses"},{"issue":"2","key":"10.1016\/j.ejmech.2025.118385_bib33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/2049-632X.12053","article-title":"Activation of influenza viruses by proteases from host cells and bacteria in the human airway epithelium","volume":"69","author":"Bottcher-Friebertshauser","year":"2013","journal-title":"Pathogens and disease"},{"key":"10.1016\/j.ejmech.2025.118385_bib34","article-title":"Ciliated cells promote high infectious potential of influenza A virus through the efficient intracellular activation of hemagglutinin","volume":"2025","author":"Guo","year":"2025","journal-title":"bioRxiv"},{"issue":"3","key":"10.1016\/j.ejmech.2025.118385_bib35","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1128\/JVI.02320-12","article-title":"Matriptase, HAT, and TMPRSS2 activate the hemagglutinin of H9N2 influenza A viruses","volume":"87","author":"Baron","year":"2013","journal-title":"J. Virol."},{"issue":"19","key":"10.1016\/j.ejmech.2025.118385_bib36","doi-asserted-by":"crossref","first-page":"10016","DOI":"10.1128\/JVI.00239-10","article-title":"TMPRSS2 and TMPRSS4 facilitate trypsin-independent spread of influenza virus in Caco-2 cells","volume":"84","author":"Bertram","year":"2010","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.ejmech.2025.118385_bib37","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/rmv.657","article-title":"Novel insights into proteolytic cleavage of influenza virus hemagglutinin","volume":"20","author":"Bertram","year":"2010","journal-title":"Rev. Med. Virol."},{"issue":"47","key":"10.1016\/j.ejmech.2025.118385_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abc3582","article-title":"TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes","volume":"5","author":"Zang","year":"2020","journal-title":"Sci. Immunol."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118385_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009500","article-title":"The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways","volume":"17","author":"Laporte","year":"2021","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118385_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/v13030384","article-title":"TMPRSS11D and TMPRSS13 activate the SARS-CoV-2 spike protein","volume":"13","author":"Kishimoto","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2025.118385_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103255","article-title":"Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity","volume":"65","author":"Hoffmann","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejmech.2025.118385_bib42","article-title":"Optimization of Ketobenzothiazole-Based type II transmembrane serine protease inhibitors to block H1N1 influenza virus replication","author":"Colombo","year":"2023","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.118385_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114437","article-title":"Improving the selectivity of 3-amidinophenylalanine-derived matriptase inhibitors","volume":"238","author":"Pilgram","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118385_bib44","first-page":"S224","article-title":"New peptidomimetic inhibitors of matriptase to fight influenza","volume":"20","author":"Marsault","year":"2014","journal-title":"J. Pept. Sci."},{"issue":"7","key":"10.1016\/j.ejmech.2025.118385_bib45","doi-asserted-by":"crossref","first-page":"7119","DOI":"10.1021\/acs.jmedchem.4c02468","article-title":"From N-0385 to N-0920: unveiling a host-directed protease inhibitor with picomolar antiviral efficacy against prevalent SARS-CoV-2 variants","volume":"68","author":"Lemieux","year":"2025","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118385_bib46","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1038\/s41467-023-37336-9","article-title":"Factor Xa cleaves SARS-CoV-2 spike protein to block viral entry and infection","volume":"14","author":"Dong","year":"2023","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118385_bib47","doi-asserted-by":"crossref","first-page":"e00519","DOI":"10.1128\/mbio.00519-22","article-title":"Metalloproteinase-dependent and TMPRSS2-Independent cell surface entry pathway of SARS-CoV-2 requires the furin cleavage site and the S2 domain of spike protein","volume":"13","author":"Yamamoto","year":"2022","journal-title":"mBio"},{"issue":"4","key":"10.1016\/j.ejmech.2025.118385_bib48","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00144-23","article-title":"SARS-CoV-2 infection of human neurons is TMPRSS2 independent, requires endosomal cell entry, and can be blocked by inhibitors of host Phosphoinositol-5 kinase","volume":"97","author":"Kettunen","year":"2023","journal-title":"J. Virol."},{"issue":"16","key":"10.1016\/j.ejmech.2025.118385_bib49","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021107821","article-title":"TMPRSS2 expression dictates the entry route used by SARS\u2010CoV\u20102 to infect host cells","volume":"40","author":"Koch","year":"2021","journal-title":"EMBO J."},{"issue":"20","key":"10.1016\/j.ejmech.2025.118385_bib50","doi-asserted-by":"crossref","first-page":"11054","DOI":"10.1073\/pnas.96.20.11054","article-title":"Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue","volume":"96","author":"Takeuchi","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"38","key":"10.1016\/j.ejmech.2025.118385_bib51","doi-asserted-by":"crossref","first-page":"36341","DOI":"10.1074\/jbc.M304643200","article-title":"Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator Inhibitor-1B (HAI-1B), a new splice variant of HAI-1","volume":"278","author":"Kirchhofer","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118385_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-021-01294-w","article-title":"Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies","author":"Chen","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2025.118385_bib53","doi-asserted-by":"crossref","DOI":"10.1093\/clinchem\/hvaa029","article-title":"Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia","author":"Chu","year":"2020","journal-title":"Clin. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342501150X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342501150X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T02:03:27Z","timestamp":1766109807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342501150X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":53,"alternative-id":["S022352342501150X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118385","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.05.09.652710","asserted-by":"object"}]},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibitors of membrane associated serine proteases block replication of coronavirus SARS-CoV-2 and influenza virus H1N1","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118385","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118385"}}